RebrAIn is proud to announce its commitment to the Charter for the Responsible Development of Neurotechnologies, a collective initiative led by public and private stakeholders and supported by the French National Consultative Ethics (CCNE). This initiative is part of France’s national acceleration strategy for neurodegenerative diseases, neuroscience, and related technologies.
By joining this foundational initiative, RebrAIn reinforces its ambition to actively contribute to building an innovative, ethical, and sovereign ecosystem dedicated to patients and healthcare professionals
The Charter sets out guiding principles for the development of neurotechnologies based on core values: respect for human dignity, safety, transparency, data sovereignty, and co-construction with stakeholders, including patients. It ensures the protection of fundamental rights, the confidentiality of personal healthcare information, and the preservation of cognitive liberties.
“Joining this Charter means actively contributing to a high-standard industry built on strong human values,” said David Caumartin, CEO of RebrAIn.
As a pioneer in precision neuromodulation, RebrAIn is fully aligned with these values, delivering AI-powered technologies designed to improve the care pathways of patients suffering from severe neurological disorders, while ensuring robust governance of brain data.
